Fatty Acid Requirements in Preterm Infants and Their Role in Health and Disease

Clinics in Perinatology

Volumn 41, Issue 2, 2014, Pages 363-382

  Martin, Camilia R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Eicosapentaenoic acid; Linoleic acid; Lipid emulsions; Long chain polyunsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LIPID EMULSION; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; FATTY ACID;

BRAIN DEVELOPMENT; CHILD HEALTH; CHILD NUTRITION; CHRONIC LUNG DISEASE; COGNITIVE DEFECT; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE CONTROL; ENTERIC FEEDING; ESSENTIAL FATTY ACID DEFICIENCY; EVIDENCE BASED MEDICINE; FAT INTAKE; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; FETOPLACENTAL UNIT; FETUS CIRCULATION; FETUS DEVELOPMENT; GESTATIONAL AGE; HUMAN; INFANT; INFANT DISEASE; INFANT NUTRITION; INFLAMMATION; MATERNAL NUTRITION; NECROTIZING ENTEROCOLITIS; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NEWBORN SEPSIS; NONHUMAN; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; PARENTERAL NUTRITION; PERINATAL PERIOD; POSTNATAL CARE; POSTNATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; RETINA DEVELOPMENT; RETROLENTAL FIBROPLASIA; REVIEW; SEPSIS; THERAPY EFFECT; GROWTH, DEVELOPMENT AND AGING; NEWBORN; NUTRITIONAL SUPPORT; PHYSIOLOGY; PROCEDURES;

FATTY ACIDS; HUMANS; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INFANT, PREMATURE; NUTRITIONAL SUPPORT;

EID: 84901626405     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2014.02.007     Document Type: Review

References (48)

1. Gil-Sanchez A., Demmelmair H., Parrilla J.J., et al. Mechanisms involved in the selective transfer of long chain polyunsaturated fatty acids to the fetus. Front Genet 2011, 2:57.
2. Larque E., Demmelmair H., Gil-Sanchez A., et al. Placental transfer of fatty acids and fetal implications. Am J Clin Nutr 2011, 94:1908S-1913S.
3. Pagan A., Prieto-Sanchez M.T., Blanco-Carnero J.E., et al. Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus. Am J Physiol Endocrinol Metab 2013, 305:E826-E833.
4. Haggarty P. Fatty acid supply to the human fetus. Annu Rev Nutr 2010, 30:237-255.
5. Hanebutt F.L., Demmelmair H., Schiessl B., et al. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin Nutr 2008, 27:685-693.
6. Larque E., Krauss-Etschmann S., Campoy C., et al. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am J Clin Nutr 2006, 84:853-861.
7. Gil-Sanchez A., Larque E., Demmelmair H., et al. Maternal-fetal in vivo transfer of [13C]docosahexaenoic and other fatty acids across the human placenta 12 h after maternal oral intake. Am J Clin Nutr 2010, 92:115-122.
8. Lapillonne A., Jensen C.L. Reevaluation of the DHA requirement for the premature infant. Prostaglandins Leukot Essent Fatty Acids 2009, 81:143-150.
9. O'Brien J.S., Sampson E.L. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J Lipid Res 1965, 6:537-544.
10. Lauritzen L., Hansen H.S., Jorgensen M.H., et al. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 2001, 40:1-94.
11. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992, 120:S129-S138.
12. Su H.M., Corso T.N., Nathanielsz P.W., et al. Linoleic acid kinetics and conversion to arachidonic acid in the pregnant and fetal baboon. J Lipid Res 1999, 40:1304-1312.
13. Carlson S.E., Werkman S.H., Peeples J.M., et al. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci U S A 1993, 90:1073-1077.
14. Koletzko B., Braun M. Arachidonic acid and early human growth: is there a relation?. Ann Nutr Metab 1991, 35:128-131.
15. Leaf A.A., Leighfield M.J., Costeloe K.L., et al. Factors affecting long-chain polyunsaturated fatty acid composition of plasma choline phosphoglycerides in preterm infants. J Pediatr Gastroenterol Nutr 1992, 14:300-308.
16. Martin C.R., Dasilva D.A., Cluette-Brown J.E., et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr 2011, 159:743-749.e2.
17. Vanek V.W., Seidner D.L., Allen P., et al. ASPEN position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract 2012, 27:150-192.
18. Freedman S.D., Blanco P.G., Zaman M.M., et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004, 350:560-569.
19. Carnielli V.P., Wattimena D.J., Luijendijk I.H., et al. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. Pediatr Res 1996, 40:169-174.
20. Larque E., Demmelmair H., Koletzko B. Perinatal supply and metabolism of long-chain polyunsaturated fatty acids: importance for the early development of the nervous system. Ann N Y Acad Sci 2002, 967:299-310.
21. Szitanyi P., Koletzko B., Mydlilova A., et al. Metabolism of 13C-labeled linoleic acid in newborn infants during the first week of life. Pediatr Res 1999, 45:669-673.
22. Lapillonne A., Eleni dit Trolli S., Kermorvant-Duchemin E. Postnatal docosahexaenoic acid deficiency is an inevitable consequence of current recommendations and practice in preterm infants. Neonatology 2010, 98:397-403.
23. Cruz-Hernandez C., Goeuriot S., Giuffrida F., et al. Direct quantification of fatty acids in human milk by gas chromatography. J Chromatogr A 2013, 1284:174-179.
24. Valentine C.J., Morrow G., Fernandez S., et al. Docosahexaenoic acid and amino acid contents in pasteurized donor milk are low for preterm infants. J Pediatr 2010, 157:906-910.
25. Rao J.S., Ertley R.N., DeMar J.C., et al. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol Psychiatry 2007, 12:151-157.
26. Fretham S.J., Carlson E.S., Georgieff M.K. Neuronal-specific iron deficiency dysregulates mammalian target of rapamycin signaling during hippocampal development in nonanemic genetic mouse models. J Nutr 2013, 143:260-266.
27. Lonze B.E., Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002, 35:605-623.
28. Malamitsi-Puchner A., Economou E., Rigopoulou O., et al. Perinatal changes of brain-derived neurotrophic factor in pre- and fullterm neonates. Early Hum Dev 2004, 76:17-22.
29. Sarkadi-Nagy E., Wijendran V., Diau G.Y., et al. The influence of prematurity and long chain polyunsaturate supplementation in 4-week adjusted age baboon neonate brain and related tissues. Pediatr Res 2003, 54:244-252.
30. Manley B.J., Makrides M., Collins C.T., et al. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics 2011, 128:e71-e77.
31. Skouroliakou M., Konstantinou D., Agakidis C., et al. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/omega-3-PUFA-containing or soybean-based lipid emulsions. Nutr Clin Pract 2012, 27:817-824.
32. Ma L., Li N., Liu X., et al. Arginyl-glutamine dipeptide or docosahexaenoic acid attenuate hyperoxia-induced lung injury in neonatal mice. Nutrition 2012, 28:1186-1191.
33. Rogers L.K., Valentine C.J., Pennell M., et al. Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. J Nutr 2011, 141:214-222.
34. Lu J., Jilling T., Li D., et al. Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Pediatr Res 2007, 61:427-432.
35. Marion-Letellier R., Dechelotte P., Iacucci M., et al. Dietary modulation of peroxisome proliferator-activated receptor gamma. Gut 2009, 58:586-593.
36. Marion-Letellier R., Savoye G., Beck P.L., et al. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis 2013, 19:650-661.
37. Pawlik D., Lauterbach R., Walczak M., et al. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study. JPEN J Parenter Enteral Nutr 2013, [Epub ahead of print].
38. Connor K.M., SanGiovanni J.P., Lofqvist C., et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007, 13:868-873.
39. Schulzke S.M., Patole S.K., Simmer K. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2011, (2). CD000375.
40. Stoll B.J., Hansen N.I., Adams-Chapman I., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292:2357-2365.
41. Antonietta Ajmone-Cat M., Lavinia Salvatori M., De Simone R., et al. Docosahexaenoic acid modulates inflammatory and antineurogenic functions of activated microglial cells. J Neurosci Res 2012, 90:575-587.
42. Williams J.J., Mayurasakorn K., Vannucci S.J., et al. N-3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic-ischemic injury in neonatal mice. PLoS One 2013, 8:e56233.
43. D'Ascenzo R., D'Egidio S., Angelini L., et al. Parenteral nutrition of preterm infants with a lipid emulsion containing 10% fish oil: effect on plasma lipids and long-chain polyunsaturated fatty acids. J Pediatr 2011, 159:33-38.e1.
44. Klein C.J., Havranek T.G., Revenis M.E., et al. Plasma fatty acids in premature infants with hyperbilirubinemia: before-and-after nutrition support with fish oil emulsion. Nutr Clin Pract 2013, 28:87-94.
45. Torrejon C., Jung U.J., Deckelbaum R.J. n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms. Prostaglandins Leukot Essent Fatty Acids 2007, 77:319-326.
46. Lapillonne A., Groh-Wargo S., Gonzalez C.H., et al. Lipid needs of preterm infants: updated recommendations. J Pediatr 2013, 162:S37-S47.
47. Howles P.N., Stemmerman G.N., Fenoglio-Preiser C.M., et al. Carboxyl ester lipase activity in milk prevents fat-derived intestinal injury in neonatal mice. Am J Physiol 1999, 277:G653-G661.
48. Makrides M. DHA supplementation during the perinatal period and neurodevelopment: do some babies benefit more than others?. Prostaglandins Leukot Essent Fatty Acids 2013, 88:87-90.